Overview

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy and safety of gevokizumab in treating Behcet's disease uveitis (BDU).
Phase:
Phase 3
Details
Lead Sponsor:
XOMA (US) LLC